Sillerman Stockholders File Amendments to Rule 13e-3 Transaction Statement with Respect to CKx Tender Offer

Robert F.X. Sillerman, Sillerman Capital Holdings, L.P and Laura Sillerman (the “Sillerman Stockholders”) have announced that, on June 8, 2011 and June 13, 2011, they amended and supplemented the Rule 13e-3 Transaction Statement that they filed with the Securities and Exchange Commission (“SEC”) on May 26, 2011, relating to the tender offer by Colonel Offeror Sub, LLC to acquire all of the outstanding shares of CKx, Inc. common stock at an offer price of $5.50 per share. The Sillerman Stockholders’ Rule 13e-3 Transaction Statement refers to the Schedule TO Tender Offer Statement filed by Colonel Offeror Sub, LLC and certain other persons with the SEC in respect of the tender offer, and the Offer to Purchase that is filed as an exhibit to that document. CKx stockholders are referred to the Sillerman Stockholders’ Rule 13e-3 Transaction Statement, as amended, and the disclosure that it references in the Schedule TO and Offer to Purchase of Colonel Offer Sub, LLC, for information concerning the Sillerman Stockholders and the disclosure of the Sillerman Stockholders in respect of the offer and the related merger transaction which these documents discuss.

IMPORTANT NOTICE: This press release is neither an offer to purchase nor a solicitation of an offer to sell shares of CKx. Colonel Offer Sub, LLC and certain other persons have filed a combined Tender Offer Statement and Rule 13e-3 Transaction Statement filed under cover of Schedule TO with the SEC, and has mailed the Offer to Purchase, forms of letter of transmittal and related documents to CKx stockholders. CKx has filed with the SEC, and has mailed to CKx stockholders, a solicitation/recommendation statement on Schedule 14D-9.

These documents are available at no charge at the SEC’s website at www.sec.gov. Also, according to the Offer to Purchase, copies of the Offer to Purchase and the related materials may be obtained for free by directing a request by mail to Innisfree M&A Incorporated, 501 Madison Avenue, 20th Floor, New York, NY 10022 or by calling toll-free [phone], or by directing a request by mail to Goldman, Sachs & Co., 200 West Street, New York, NY 10282, or by calling toll-free [phone].